Indegene Limited — Others, 31-07-2025: ESOP/ESOS/ESPS

Indegene Limited's Board of Directors has approved the financial results for the quarter ended June 30, 2025, encompassing both standalone and consolidated performance. These results have received an unmodified opinion from the auditors, assuring their accuracy. Additionally, the Board greenlit the allotment of shares under the ESOP 2020 Plan. This announcement provides investors with crucial updates on the company's latest financial health and its strategy for employee retention and incentivization, directly impacting stakeholder value.